Nancy Bartlett

2018

Genetics and pathogenesis of diffuse large B-Cell lymphoma

Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., Hodson, D. J., Xiao, W., Yu, X., Yang, Y., Zhao, H., Xu, W., Liu, X., Zhou, B., Du, W. & Chan, W. C. & 20 others, Jaffe, E. S., Gascoyne, R. D., Connors, J. M., Campo, E., Lopez-Guillermo, A., Rosenwald, A., Ott, G., Delabie, J., Rimsza, L. M., Tay Kuang Wei, K., Zelenetz, A. D., Leonard, J. P., Bartlett, N. L., Tran, B., Shetty, J., Zhao, Y., Soppet, D. R., Pittaluga, S., Wilson, W. H. & Staudt, L. M., Apr 12 2018, In: New England Journal of Medicine. 378, 15, p. 1396-1407 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

1415 Scopus citations

Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL

Woyach, J. A., Ruppert, A. S., Heerema, N. A., Zhao, W., Booth, A. M., Ding, W., Bartlett, N. L., Brander, D. M., Barr, P. M., Rogers, K. A., Parikh, S. A., Coutre, S., Hurria, A., Brown, J. R., Lozanski, G., Blachly, J. S., Ozer, H. G., Major-Elechi, B., Fruth, B. & Nattam, S. & 11 others, Larson, R. A., Erba, H., Litzow, M., Owen, C., Kuzma, C., Abramson, J. S., Little, R. F., Smith, S. E., Stone, R. M., Mandrekar, S. J. & Byrd, J. C., Dec 27 2018, In: New England Journal of Medicine. 379, 26, p. 2517-2528 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

710 Scopus citations

In situ vaccination with a tlr9 agonist and local low-dose radiation induces systemic responses in untreated indolent lymphoma

Frank, M. J., Reagan, P. M., Bartlett, N. L., Gordon, L. I., Friedberg, J. W., Czerwinski, D. K., Long, S. R., Hoppe, R. T., Janssen, R., Candia, A. F., Coffman, R. L. & Levy, R., Oct 2018, In: Cancer discovery. 8, 10, p. 1258-1269 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

135 Scopus citations

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma

Herrera, A. F., Moskowitz, A. J., Bartlett, N. L., Vose, J. M., Ramchandren, R., Feldman, T. A., LaCasce, A. S., Ansell, S. M., Moskowitz, C. H., Fenton, K., Ogden, C. A., Taft, D., Zhang, Q., Kato, K., Campbell, M. & Advani, R. H., Mar 15 2018, In: Blood. 131, 11, p. 1183-1194 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

256 Scopus citations

Management of relapsed/refractory classical Hodgkin lymphoma in transplant-ineligible patients

Mehta-Shah, N. & Bartlett, N. L., Apr 12 2018, In: Blood. 131, 15, p. 1698-1703 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

21 Scopus citations

Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study

Goyal, S., Oak, E., Luo, J., Cashen, A. F., Carson, K., Fehniger, T., DiPersio, J., Bartlett, N. L. & Wagner-Johnston, N. D., Feb 1 2018, In: Leukemia and Lymphoma. 59, 2, p. 357-362 6 p.

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis

Henderson, T. O., Parsons, S. K., Wroblewski, K. E., Chen, L., Hong, F., Smith, S. M., McNeer, J. L., Advani, R. H., Gascoyne, R. D., Constine, L. S., Horning, S., Bartlett, N. L., Shah, B., Connors, J. M., Leonard, J. I., Kahl, B. S., Kelly, K. M., Schwartz, C. L., Li, H. & Friedberg, J. W. & 3 others, Friedman, D. L., Gordon, L. I. & Evens, A. M., Jan 1 2018, In: Cancer. 124, 1, p. 136-144 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

46 Scopus citations

Rituximab plus lenalidomide in advanced untreated follicular lymphoma

Morschhauser, F., Fowler, N. H., Feugier, P., Bouabdallah, R., Tilly, H., Palomba, M. L., Fruchart, C., Libby, E. N., Casasnovas, R. O., Flinn, I. W., Haioun, C., Maisonneuve, H., Ysebaert, L., Bartlett, N. L., Bouabdallah, K., Brice, P., Ribrag, V., Daguindau, N., Gouill, S. L. & Pica, G. M. & 14 others, Garcia-Sancho, A. M., López-Guillermo, A., Larouche, J. F., Ando, K., Da Silva, M. G., André, M., Zachée, P., Sehn, L. H., Tobinai, K., Cartron, G., Liu, D., Wang, J., Xerri, L. & Salles, G. A., Sep 6 2018, In: New England Journal of Medicine. 379, 10, p. 934-946 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

252 Scopus citations

Single-agent ibrutinib in relapsed or refractory follicular lymphoma: A phase 2 consortium trial

Bartlett, N. L., Costello, B. A., LaPlant, B. R., Ansell, S. M., Kuruvilla, J. G., Reeder, C. B., Thye, L. S., Anderson, D. M., Krysiak, K., Ramirez, C., Qi, J., Siegel, B. A., Griffith, M., Griffith, O. L., Gomez, F. & Fehniger, T. A., Jan 11 2018, In: Blood. 131, 2, p. 182-190 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

115 Scopus citations

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: Extended phase 3 results from RESONATE-2

Barr, P. M., Robak, T., Owen, C., Tedeschi, A., Bairey, O., Bartlett, N. L., Burger, J. A., Hillmen, P., Coutre, S., Devereux, S., Grosicki, S., McCarthy, H., Li, J., Simpson, D., Offner, F., Moreno, C., Zhou, C., Styles, L., James, D. & Kipps, T. J. & 1 others, Ghia, P., Aug 31 2018, In: Haematologica. 103, 9, p. 1502-1510 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

109 Scopus citations

2017

A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma

Maly, J. J., Christian, B. A., Zhu, X., Wei, L., Sexton, J. L., Jaglowski, S. M., Devine, S. M., Fehniger, T. A., Wagner-Johnston, N. D., Phelps, M. A., Bartlett, N. L. & Blum, K. A., Jun 2017, In: Clinical Lymphoma, Myeloma and Leukemia. 17, 6, p. 347-353 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

24 Scopus citations

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance)

Martin, P., Jung, S. H., Pitcher, B., Bartlett, N. L., Blum, K. A., Shea, T., Hsi, E. D., Ruan, J., Smith, S. E., Leonard, J. P. & Cheson, B. D., Nov 2017, In: Annals of Oncology. 28, 11, p. 2806-2812 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

72 Scopus citations

Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-Cell lymphoma

Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., Timmerman, J. M., Stiff, P. J., Friedberg, J. W., Flinn, I. W., Goy, A., Hill, B. T., Smith, M. R., Deol, A., Farooq, U. & McSweeney, P. & 20 others, Munoz, J., Avivi, I., Castro, J. E., Westin, J. R., Chavez, J. C., Ghobadi, A., Komanduri, K. V., Levy, R., Jacobsen, E. D., Witzig, T. E., Reagan, P., Bot, A., Rossi, J., Navale, L., Jiang, Y., Aycock, J., Elias, M., Chang, D., Wiezorek, J. & Go, W. Y., Dec 28 2017, In: New England Journal of Medicine. 377, 26, p. 2531-2544 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

3919 Scopus citations

Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry

Bartlett, N. L., Smith, M. R., Siddiqi, T., Advani, R. H., O’Connor, O. A., Sharman, J. P., Feldman, T., Savage, K. J., Shustov, A. R., Diefenbach, C. S., Oki, Y., Palanca-Wessels, M. C., Uttarwar, M., Li, M., Yang, J. & Jacobsen, E. D., Jul 3 2017, In: Leukemia and Lymphoma. 58, 7, p. 1607-1616 10 p.

Research output: Contribution to journal › Article › peer-review

47 Scopus citations

Emerging role of novel therapies in Hodgkin lymphoma: Proceed with caution

Bartlett, N. L., Dec 8 2017, In: Hematology. 2017, 1, p. 317-323 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma

Pro, B., Advani, R., Brice, P., Bartlett, N. L., Rosenblatt, J. D., Illidge, T., Matous, J., Ramchandren, R., Fanale, M., Connors, J. M., Fenton, K., Huebner, D., Pinelli, J. M., Kennedy, D. A. & Shustov, A., Dec 21 2017, In: Blood. 130, 25, p. 2709-2717 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

173 Scopus citations

Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

Lee, Y. S., Liu, J., Fricano, K. A., Webb, E. M., Toolsie, D. R., Jones, S., Rhoads, J. A., Vij, R., Cashen, A. F., Abboud, C. N., Westervelt, P., Bartlett, N. L., Dipersio, J. F., Kreisel, F. H. & Lim, K. H., Dec 2017, In: Biology of Blood and Marrow Transplantation. 23, 12, p. 2199-2204 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

8 Scopus citations

Long-term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non-Hodgkin lymphoma

Martin, P., Chen, Z., Cheson, B. D., Robinson, K. S., Williams, M., Rajguru, S. A., Friedberg, J. W., van der Jagt, R. H., LaCasce, A. S., Joyce, R., Ganjoo, K. N., Bartlett, N. L., Lemieux, B., VanderWalde, A., Herst, J., Szer, J., Bar, M. H., Cabanillas, F., Dodds, A. J. & Montgomery, P. G. & 4 others, Pressnail, B., Ellis, T., Smith, M. R. & Leonard, J. P., Jul 2017, In: British Journal of Haematology. 178, 2, p. 250-256 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

32 Scopus citations

Magnetic resonance image guided radiation therapy for primary splenic diffuse large B-cell lymphoma: A teaching case

Fischer-Valuck, B. W., Green, O., Mazur, T., Li, H., Chundury, A., Rao, Y. J., Bartlett, N. L., Mutic, S. & Huang, J., Jan 1 2017, In: Practical Radiation Oncology. 7, 1, p. e23-e26

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R

Giulino-Roth, L., O'Donohue, T., Chen, Z., Bartlett, N. L., LaCasce, A., Martin-Doyle, W., Barth, M. J., Davies, K., Blum, K. A., Christian, B., Casulo, C., Smith, S. M., Godfrey, J., Termuhlen, A., Oberley, M. J., Alexander, S., Weitzman, S., Appel, B., Mizukawa, B. & Svoboda, J. & 12 others, Afify, Z., Pauly, M., Dave, H., Gardner, R., Stephens, D. M., Zeitler, W. A., Forlenza, C., Levine, J., Williams, M. E., Sima, J. L., Bollard, C. M. & Leonard, J. P., Dec 2017, In: British Journal of Haematology. 179, 5, p. 739-747 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

103 Scopus citations

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Locke, F. L., Neelapu, S. S., Bartlett, N. L., Siddiqi, T., Chavez, J. C., Hosing, C. M., Ghobadi, A., Budde, L. E., Bot, A., Rossi, J. M., Jiang, Y., Xue, A. X., Elias, M., Aycock, J., Wiezorek, J. & Go, W. Y., Jan 4 2017, In: Molecular Therapy. 25, 1, p. 285-295 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

497 Scopus citations

Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma

Krysiak, K., Gomez, F., White, B. S., Matlock, M., Miller, C. A., Trani, L., Fronick, C. C., Fulton, R. S., Kreisel, F., Cashen, A. F., Carson, K., Berrien-Elliott, M. M., Bartlett, N. L., Griffith, M., Griffith, O. L. & Fehniger, T. A., Jan 26 2017, In: Blood. 129, 4, p. 473-483 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

136 Scopus citations

Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials

Smith, S. M., Pitcher, B. N., Jung, S. H., Bartlett, N. L., Wagner-Johnston, N., Park, S. I., Richards, K. L., Cashen, A. F., Jaslowski, A., Smith, S. E., Cheson, B. D., Hsi, E. & Leonard, J. P., Apr 1 2017, In: The Lancet Haematology. 4, 4, p. e176-e182

Research output: Contribution to journal › Article › peer-review

Open Access

73 Scopus citations

2016

A phase I/II multicenter, open-label study of the oral histone deacetylase inhibitor abexinostat in relapsed/refractory lymphoma

Evens, A. M., Balasubramanian, S., Vose, J. M., Harb, W., Gordon, L. I., Langdon, R., Sprague, J., Sirisawad, M., Mani, C., Yue, J., Luan, Y., Horton, S., Graef, T. & Bartlett, N. L., Mar 1 2016, In: Clinical Cancer Research. 22, 5, p. 1059-1066 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

69 Scopus citations

A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)

Flinn, I. W., Bartlett, N. L., Blum, K. A., Ardeshna, K. M., Lacasce, A. S., Flowers, C. R., Shustov, A. R., Thress, K. S., Mitchell, P., Zheng, F., Skolnik, J. M. & Friedberg, J. W., Feb 1 2016, In: European Journal of Cancer. 54, p. 11-17 7 p.

Research output: Contribution to journal › Article › peer-review

66 Scopus citations

A safety evaluation of brentuximab vedotin for the treatment of Hodgkin lymphoma

Oak, E. & Bartlett, N. L., Jun 2 2016, In: Expert Opinion on Drug Safety. 15, 6, p. 875-882 8 p.

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Clinical characteristics and outcomes of patients with Hodgkin lymphoma with central nervous system involvement: An international multicenter collaboration

Cheah, C. Y., Bröckelmann, P. J., Chihara, D., Moskowitz, A. J., Engert, A., Jerkeman, M., El-Galaly, T. C., Augustson, B., Vose, J., Bartlett, N. L., Villa, D., Connors, J. M., Feldman, T., Pinnix, C. C., Milgrom, S. A., Dabaja, B., Oki, Y. & Fanale, M. A., Sep 1 2016, In: American journal of hematology. 91, 9, p. 894-899 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

13 Scopus citations

Expression of TIA1 and PAX5 in Classical Hodgkin Lymphoma at Initial Diagnosis May Predict Clinical Outcome

Nguyen, T. D. T., Frater, J. L., Klein, J., Chen, L., Bartlett, N. L., Foyil, K. V. & Kreisel, F. H., Jul 1 2016, In: Applied Immunohistochemistry and Molecular Morphology. 24, 6, p. 383-391 9 p.

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): A randomised, double-blind, phase 3 study

Chanan-Khan, A., Cramer, P., Demirkan, F., Fraser, G., Silva, R. S., Grosicki, S., Pristupa, A., Janssens, A., Mayer, J., Bartlett, N. L., Dilhuydy, M. S., Pylypenko, H., Loscertales, J., Avigdor, A., Rule, S., Villa, D., Samoilova, O., Panagiotidis, P., Goy, A. & Mato, A. & 9 others, Pavlovsky, M. A., Karlsson, C., Mahler, M., Salman, M., Sun, S., Phelps, C., Balasubramanian, S., Howes, A. & Hallek, M., Feb 1 2016, In: The Lancet Oncology. 17, 2, p. 200-211 12 p.

Research output: Contribution to journal › Article › peer-review

380 Scopus citations

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

Chen, R., Allibone, S., Bartlett, N. L., Brice, P., Chen, A., Pose, K., Rich, L., Bonthapally, V., Garfin, P. M. & Fanale, M., Apr 6 2016, In: OncoTargets and Therapy. 9, p. 2027-2034 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103

Ujjani, C. S., Jung, S. H., Pitcher, B., Martin, P., Park, S. I., Blum, K. A., Smith, S. M., Czuczman, M., Davids, M. S., Levine, E., Lewis, L. D., Smith, S. E., Bartlett, N. L., Leonard, J. P. & Cheson, B. D., Nov 24 2016, In: Blood. 128, 21, p. 2510-2516 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

49 Scopus citations

Phase I and II study of induction chemotherapy with methotrexate, rituximab, and temozolomide, followed by whole-brain radiotherapy and postirradiation temozolomide for primary CNS lymphoma: NRG oncology RTOG 0227

Glass, J., Won, M., Schultz, C. J., Brat, D., Bartlett, N. L., Suh, J. H., Werner-Wasik, M., Fisher, B. J., Liepman, M. K., Augspurger, M., Bokstein, F., Bovi, J. A., Solhjem, M. C. & Meh, M. P., May 10 2016, In: Journal of Clinical Oncology. 34, 14, p. 1620-1625 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

105 Scopus citations

The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and in Vivo Clearance of B Cell Lymphomas

Rosario, M., Liu, B., Kong, L., Collins, L. I., Schneider, S. E., Chen, X., Han, K., Jeng, E. K., Rhode, P. R., Leong, J. W., Schappe, T., Jewell, B. A., Keppel, C. R., Shah, K., Hess, B., Romee, R., Piwnica-Worms, D. R., Cashen, A. F., Bartlett, N. L. & Wong, H. C. & 1 others, Fehniger, T. A., Feb 1 2016, In: Clinical Cancer Research. 22, 3, p. 596-608 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

121 Scopus citations

US intergroup trial of response-adapted therapy for stage III to IV Hodgkin lymphoma using early interim fluorodeoxyglucose-positron emission tomography imaging: Southwest Oncology Group S0816

Press, O. W., Li, H., Schöder, H., Straus, D. J., Moskowitz, C. H., LeBlanc, M., Rimsza, L. M., Bartlett, N. L., Evens, A. M., Mittra, E. S., LaCasce, A. S., Sweetenham, J. W., Barr, P. M., Fanale, M. A., Knopp, M. V., Noy, A., Hsi, E. D., Cook, J. R., Lechowicz, M. J. & Gascoyne, R. D. & 5 others, Leonard, J. P., Kahl, B. S., Cheson, B. D., Fisher, R. I. & Friedberg, J. W., Jun 10 2016, In: Journal of Clinical Oncology. 34, 17, p. 2020-2027 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

225 Scopus citations

2015

A young woman with blurred vision and distal paresthesias

Kung, N. H., Bartlett, N. L., Yaseen, N. R., Van Stavern, G. P. & Bucelli, R. C., Dec 2015, In: JAMA Neurology. 72, 12, p. 1519-1526 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression

Jacobsen, E. D., Sharman, J. P., Oki, Y., Advani, R. H., Winter, J. N., Bello, C. M., Spitzer, G., Palanca-Wessels, M. C., Kennedy, D. A., Levine, P., Yang, J. & Bartlett, N. L., Feb 26 2015, In: Blood. 125, 9, p. 1394-1402 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

242 Scopus citations

Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma

Carson, K. R., Riedell, P., Lynch, R., Nabhan, C., Wildes, T. M., Liu, W., Ganti, A., Roop, R., Sanfilippo, K. M., O'Brian, K., Liu, J., Bartlett, N. L., Cashen, A., Wagner-Johnston, N., Fehniger, T. A. & Colditz, G. A., May 1 2015, In: Journal of Geriatric Oncology. 6, 3, p. 211-218 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

51 Scopus citations

Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: A randomized, double-blind, placebo-controlled phase 2b trial

Fayad, L., Ansell, S. M., Advani, R., Coiffier, B., Stuart, R., Bartlett, N. L., Forero-Torres, A., Kuliczkowski, K., Belada, D., Ng, E. & Drachman, J. G., Sep 2 2015, In: Leukemia and Lymphoma. 56, 9, p. 2569-2578 10 p.

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era

Diefenbach, C. S., Li, H., Hong, F., Gordon, L. I., Fisher, R. I., Bartlett, N. L., Crump, M., Gascoyne, R. D., Wagner, H., Stiff, P. J., Cheson, B. D., Stewart, D. A., Kahl, B. S., Friedberg, J. W., Blum, K. A., Habermann, T. M., Tuscano, J. M., Hoppe, R. T., Horning, S. J. & Advani, R. H., Nov 2015, In: British Journal of Haematology. 171, 4, p. 530-538 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

54 Scopus citations

Extended treatment with brentuximab vedotin in patients with relapsed or refractory CD30-positive hematological malignancies

Forero-Torres, A., Bartlett, N. L., Berryman, R. B., Chen, R., Matous, J. V., Fanale, M. A., O'Connor, O. A., Olshefski, R., Smith, S. E., Huebner, D., Levine, P. L., Grove, L. E. & Gopal, A. K., Apr 1 2015, In: Leukemia and Lymphoma. 56, 4, p. 1151-1153 3 p.

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort

Evens, A. M., Kanakry, J. A., Sehn, L. H., Kritharis, A., Feldman, T., Kroll, A., Gascoyne, R. D., Abramson, J. S., Petrich, A. M., Hernandez-Ilizaliturri, F. J., Al-Mansour, Z., Adeimy, C., Hemminger, J., Bartlett, N. L., Mato, A., Caimi, P. F., Advani, R. H., Klein, A. K., Nabhan, C. & Smith, S. M. & 7 others, Fabregas, J. C., Lossos, I. S., Press, O. W., Fenske, T. S., Friedberg, J. W., Vose, J. M. & Blum, K. A., Sep 1 2015, In: American journal of hematology. 90, 9, p. 778-783 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

72 Scopus citations

Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia

Burger, J. A., Tedeschi, A., Barr, P. M., Robak, T., Owen, C., Ghia, P., Bairey, O., Hillmen, P., Bartlett, N. L., Li, J., Simpson, D., Grosicki, S., Devereux, S., McCarthy, H., Coutre, S., Quach, H., Gaidano, G., Maslyak, Z., Stevens, D. A. & Janssens, A. & 14 others, Offner, F., Mayer, J., O'Dwyer, M., Hellmann, A., Schuh, A., Siddiqi, T., Polliack, A., Tam, C. S., Suri, D., Cheng, M., Clow, F., Styles, L., James, D. F. & Kipps, T. J., Dec 17 2015, In: New England Journal of Medicine. 373, 25, p. 2425-2437 13 p.

Research output: Contribution to journal › Article › peer-review

Open Access

1270 Scopus citations

Outcomes of transformed follicular lymphoma in the modern era: A report from the National LymphoCare Study (NLCS)

Wagner-Johnston, N. D., Link, B. K., Byrtek, M., Dawson, K. L., Hainsworth, J., Flowers, C. R., Friedberg, J. W. & Bartlett, N. L., Aug 13 2015, In: Blood. 126, 7, p. 851-857 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

156 Scopus citations

Phase II intergroup trial of alisertib in relapsed and refractory peripheral T-cell lymphoma and transformed Mycosis fungoides: SWOG 1108

Barr, P. M., Li, H., Spier, C., Mahadevan, D., LeBlanc, M., Ul Haq, M., Huber, B. D., Flowers, C. R., Wagner-Johnston, N. D., Horwitz, S. M., Fisher, R. I., Cheson, B. D., Smith, S. M., Kahl, B. S., Bartlett, N. L. & Friedberg, J. W., Jul 20 2015, In: Journal of Clinical Oncology. 33, 21, p. 2399-2404 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

102 Scopus citations

Randomized phase III trial comparing ABVD plus radiotherapy with the Stanford V regimen in patients with stages I or II locally extensive, bulky mediastinal Hodgkin lymphoma: A subset analysis of the North American Intergroup E2496 trial

Advani, R. H., Hong, F., Fisher, R. I., Bartlett, N. L., Robinson, K. S., Gascoyne, R. D., Wagner, H., Stiff, P. J., Cheson, B. D., Stewart, D. A., Gordon, L. I., Kahl, B. S., Friedberg, J. W., Blum, K. A., Habermann, T. M., Tuscano, J. M., Hoppe, R. T. & Horning, S. J., Jun 10 2015, In: Journal of Clinical Oncology. 33, 17, p. 1936-1942 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

27 Scopus citations

Randomized trial of lenalidomide alone versus lenalidomide plus rituximab in patients with recurrent follicular lymphoma: CALGB 50401 (Alliance)

Leonard, J. P., Jung, S. H., Johnson, J., Pitcher, B. N., Bartlett, N. L., Blum, K. A., Czuczman, M., Giguere, J. K. & Cheson, B. D., Nov 1 2015, In: Journal of Clinical Oncology. 33, 31, p. 3635-3640 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

156 Scopus citations

Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: Final results of a phase II trial (CALGB 50501)

Morrison, V. A., Jung, S. H., Johnson, J., Lacasce, A., Blum, K. A., Bartlett, N. L., Pitcher, B. N. & Cheson, B. D., Apr 1 2015, In: Leukemia and Lymphoma. 56, 4, p. 958-964 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

33 Scopus citations

2014

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma

Levy, R., Ganjoo, K. N., Leonard, J. P., Vose, J. M., Flinn, I. W., Ambinder, R. F., Connors, J. M., Berinstein, N. L., Belch, A. R., Bartlett, N. L., Nichols, C., Emmanouilides, C. E., Timmerman, J. M., Gregory, S. A., Link, B. K., Inwards, D. J., Freedman, A. S., Matous, J. V., Robertson, M. J. & Kunkel, L. A. & 6 others, Ingolia, D. E., Gentles, A. J., Liu, C. L., Tibshirani, R., Alizadeh, A. A. & Denney, D. W., Jun 10 2014, In: Journal of Clinical Oncology. 32, 17, p. 1797-1803 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

70 Scopus citations

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

De Vos, S., Forero-Torres, A., Ansell, S. M., Kahl, B., Cheson, B. D., Bartlett, N. L., Furman, R. R., Winter, J. N., Kaplan, H., Timmerman, J., Whiting, N. C., Drachman, J. G. & Advani, R., Jun 12 2014, In: Journal of Hematology and Oncology. 7, 1, 44.

Research output: Contribution to journal › Article › peer-review

Open Access

78 Scopus citations

Brentuximab vedotin in patients aged 60 years or older with relapsed or refractory CD30-positive lymphomas: A retrospective evaluation of safety and efficacy

Gopal, A. K., Bartlett, N. L., Forero-Torres, A., Younes, A., Chen, R., Friedberg, J. W., Matous, J. V., Shustov, A. R., Smith, S. E., Zain, J., O'Meara, M. M. & Fanale, M. A., Oct 1 2014, In: Leukemia and Lymphoma. 55, 10, p. 2328-2334 7 p.

Research output: Contribution to journal › Article › peer-review

44 Scopus citations

Nancy Bartlett

Research output

Search results